The effect of the PNPLA3 I148M genetic variation is significant, with each allele having approximately a 2-fold increase in the odds of NAFLD and a 3-fold increase in the odds of NASH and HCC (118). Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.